Перспективы использования будесонида в детской респираторной медицине
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». 3-е изд., испр. и доп. М.: Атмосфера, 2008.
2. Jeffery PK, Godfrey RWA, Adelroth E et al. Effects of treatment on airway inflammation and thickening of reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890–9.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697–704.
4. Pulmicort (budesonid). International product monograph. AstraZeneca, 2008.
5. Геппе Н.А., Бераиа Т.Т. Ингаляционные глюкокортикостероиды в терапии бронхиальной астмы у детей. Cons Med. Педиатрия. 2008; 1.
6. Obase Y, Rytila P, Metso T et al. Effects of Inhaled Corticosteroids on Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinase-1 in the Airways of Asthmatic Children. Int Arch Allergy Immunol 2009; 151 (3): 247–54.
7. Княжеская Н.П. Ингаляционные глюкокортикостероиды – основа противовоспалительной терапии бронхиальной астмы. Cons Med. Пульмонология. 2006; 1.
8. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once versus twice-daily administration: meta-analysis. Respirology 2004; 9 (4): 528–34.
9. Ponce Castro H, Rodríguez Espino S, Rodríguez Orozco AR. Administration of budesonide (inhaled steroid) to children to control intermittent asthma. Rev Alerg Mex 2009; 56 (1): 9–12.
10. Decimo F, Maiello N, Miraglia Del Giudice M et al. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. Int J Immunopathol Pharmacol 2009; 22 (2): 363–70.
11. Denny FW, Murphy TF, Clyde WA et al. Croup: an 11-year study in pediatric practice. Pediatrics 1983; 71: 871–6.
12. Ewig JM. Croup. Pediat Ann 2002; 31: 125–30.
13. Russell K, Wiebe N, Saenz A et al. Glucocorticoids for croup. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001955. DOI: 10.1002/14651858. CD001955. pub2.
14. Klassen TP. Croup. A current perspective. Pediatr Clin North Am 1999; 46: 1167–78.
15. Husby S, Agertoft L, Mortensen S, Pedersen S. Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Arch Dis Child 1993; 68: 352–5.
16. Johnson D. Croup. Clin Evid (Online). 2009 Mar 10;2009. pii: 0321.
17. Kuo HT, Lin HC, Tsai CH et al. A Follow-up Study of Preterm Infants Given Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants. J Pediat 2010.
18. Halliday HL, Ehrenkranz RA, Doyle LW. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009; 1: CD001145.
19. Kaditis AG, Winnie G, Syrogiannopoulos GA. Antiinflammatory pharmacotherapy for wheezing in preschool children. Pediat Pulmonol 2007; 42: 407–20.
20. Campusano L, Pastenes M, Fontecilla C et al. Response to budesonide among atopic and non-atopic infants/preschoolers with recurrent wheezing. Allergol Immunopathol (Madr). 2010; 38 (1): 31–6.
21. Nicolini G, Cremonesi G, Melani AS. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate. Pulm Pharmacol Ther 2009.
22. Shepherd J, Rogers G, Anderson R et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess 2008; 12 (19): iii–iv, 1–360.
23. Геппе Н.А. Небулайзерная терапия при бронхиальной астме у детей. Пульмонология. 1999; с. 42–8.
24. Зайцева О.В., Зайцева С.В. Аэрозольтерапия в лечении заболеваний органов дыхания у детей. Cons Med. Педиатрия. 2008; 1.
25. Авдеев С.Н. Небулайзеры для длительной поддерживающей терапии обструктивных заболеваний легких. Cons Med 10 (10), www.consilium-medicum.com.
26. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001; 18: 228–42.
27. Чучалин А.Г., Княжеская Н.П., Потапова М.О. Место небулайзеров в ингаляционной терапии хронических обструктивных заболеваний легких. Рус. мед. журн. 2006; 14 (7): 521–4.
28. Newman SP, Pitcairn GR, Pickford et al. The MicroAir electronicmesh nebuliser deposits aerosol in the lungs more efficiently than a conventional jet nebuliser. Drug Delivery to the Lungs XV, The Aerosol Society, London, 2004; 228–31.
29. Schueepp KG, Devadason SG, Roller C et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir Med 2009; 103 (11): 1738–45.
2. Jeffery PK, Godfrey RWA, Adelroth E et al. Effects of treatment on airway inflammation and thickening of reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890–9.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697–704.
4. Pulmicort (budesonid). International product monograph. AstraZeneca, 2008.
5. Геппе Н.А., Бераиа Т.Т. Ингаляционные глюкокортикостероиды в терапии бронхиальной астмы у детей. Cons Med. Педиатрия. 2008; 1.
6. Obase Y, Rytila P, Metso T et al. Effects of Inhaled Corticosteroids on Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinase-1 in the Airways of Asthmatic Children. Int Arch Allergy Immunol 2009; 151 (3): 247–54.
7. Княжеская Н.П. Ингаляционные глюкокортикостероиды – основа противовоспалительной терапии бронхиальной астмы. Cons Med. Пульмонология. 2006; 1.
8. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once versus twice-daily administration: meta-analysis. Respirology 2004; 9 (4): 528–34.
9. Ponce Castro H, Rodríguez Espino S, Rodríguez Orozco AR. Administration of budesonide (inhaled steroid) to children to control intermittent asthma. Rev Alerg Mex 2009; 56 (1): 9–12.
10. Decimo F, Maiello N, Miraglia Del Giudice M et al. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. Int J Immunopathol Pharmacol 2009; 22 (2): 363–70.
11. Denny FW, Murphy TF, Clyde WA et al. Croup: an 11-year study in pediatric practice. Pediatrics 1983; 71: 871–6.
12. Ewig JM. Croup. Pediat Ann 2002; 31: 125–30.
13. Russell K, Wiebe N, Saenz A et al. Glucocorticoids for croup. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001955. DOI: 10.1002/14651858. CD001955. pub2.
14. Klassen TP. Croup. A current perspective. Pediatr Clin North Am 1999; 46: 1167–78.
15. Husby S, Agertoft L, Mortensen S, Pedersen S. Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Arch Dis Child 1993; 68: 352–5.
16. Johnson D. Croup. Clin Evid (Online). 2009 Mar 10;2009. pii: 0321.
17. Kuo HT, Lin HC, Tsai CH et al. A Follow-up Study of Preterm Infants Given Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants. J Pediat 2010.
18. Halliday HL, Ehrenkranz RA, Doyle LW. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009; 1: CD001145.
19. Kaditis AG, Winnie G, Syrogiannopoulos GA. Antiinflammatory pharmacotherapy for wheezing in preschool children. Pediat Pulmonol 2007; 42: 407–20.
20. Campusano L, Pastenes M, Fontecilla C et al. Response to budesonide among atopic and non-atopic infants/preschoolers with recurrent wheezing. Allergol Immunopathol (Madr). 2010; 38 (1): 31–6.
21. Nicolini G, Cremonesi G, Melani AS. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate. Pulm Pharmacol Ther 2009.
22. Shepherd J, Rogers G, Anderson R et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess 2008; 12 (19): iii–iv, 1–360.
23. Геппе Н.А. Небулайзерная терапия при бронхиальной астме у детей. Пульмонология. 1999; с. 42–8.
24. Зайцева О.В., Зайцева С.В. Аэрозольтерапия в лечении заболеваний органов дыхания у детей. Cons Med. Педиатрия. 2008; 1.
25. Авдеев С.Н. Небулайзеры для длительной поддерживающей терапии обструктивных заболеваний легких. Cons Med 10 (10), www.consilium-medicum.com.
26. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001; 18: 228–42.
27. Чучалин А.Г., Княжеская Н.П., Потапова М.О. Место небулайзеров в ингаляционной терапии хронических обструктивных заболеваний легких. Рус. мед. журн. 2006; 14 (7): 521–4.
28. Newman SP, Pitcairn GR, Pickford et al. The MicroAir electronicmesh nebuliser deposits aerosol in the lungs more efficiently than a conventional jet nebuliser. Drug Delivery to the Lungs XV, The Aerosol Society, London, 2004; 228–31.
29. Schueepp KG, Devadason SG, Roller C et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir Med 2009; 103 (11): 1738–45.
Авторы
И.К.Волков
Кафедра и клиника детских болезней ММА им. И.М.Сеченова
Кафедра и клиника детских болезней ММА им. И.М.Сеченова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.